Open innovation strategies in the UK biopharmaceutical sector

Călin Gurău and Frank Lasch

International Journal of Entrepreneurial Venturing, 2011, vol. 3, issue 4, 420-434

Abstract: In the last ten years, the paradigm of open innovation has modified the way in which the research and development process is organised and managed by high-technology firms. However, this model should be adapted to the specific characteristics and conditions of each industrial sector. Using the data collected through interviews with 23 managers of UK biopharmaceutical SMEs, this study attempts to identify the factors that may enhance the capacity of these firms to develop and manage open innovation systems. Findings indicate that the size of the firm, its organisational stage, its capability to develop partnerships and its capacity to identify partner organisations with complementary resources influence the capacity of the biopharmaceutical organisation to implement and manage open innovation systems.

Keywords: open innovation; innovation strategies; biopharmaceutical SMEs; UK biotechnology sector; United Kingdom; small and medium-sized enterprises; high technology; high tech firms; innovation management; biotech firms. (search for similar items in EconPapers)
Date: 2011
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://www.inderscience.com/link.php?id=43386 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ids:ijeven:v:3:y:2011:i:4:p:420-434

Access Statistics for this article

More articles in International Journal of Entrepreneurial Venturing from Inderscience Enterprises Ltd
Bibliographic data for series maintained by Sarah Parker ().